IPR2016-01315 - Glaxosmithkline LLC v. Fibrogen IncReport Error
Details
PATENT NUMBER
APPL. NUMBER
12928119
STATUS
Not Instituted - Merits
FILING DATE
2016-06-30
INSTITUTION DATE
2017-01-11
TERMINATION DATE
2017-01-11
AUTHOR JUDGE
Timeline
Petition
Notice of Filing Date
Notice of Filing Date
Preliminary Response
Institution Decision
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2017
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2018
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Docket
| 1 | 2016-06-30 | Petitioner | Power of Attorney | Power of Attorney |
| 2 | 2016-06-30 | Petitioner | Petition | PETITION FOR INTER PARTES REVIEW OF U.S. PATENT NO. 8,466,172 |
| 1001 | 2016-06-30 | Petitioner | U.S. Patent No. 8,466,172 | |
| 1002 | 2016-06-30 | Petitioner | Declaration of Dr. Paul Schumacker, Ph.D. | |
| 1003 | 2016-06-30 | Petitioner | Office Action dated Jan.30, 2006 | |
| 1004 | 2016-06-30 | Petitioner | Office Actions dated July 23, 2009 | |
| 1005 | 2016-06-30 | Petitioner | Examiner Interview Summary dated Feb. 5, 2013 | |
| 1006 | 2016-06-30 | Petitioner | Epstein et al., C. elegans EGL-9 | |
| 1007 | 2016-06-30 | Petitioner | Jaakkola et al., Targeting of HIF-a | |
| 1008 | 2016-06-30 | Petitioner | Semenza, Hypoxia-inducible factor 1... | |
| 1009 | 2016-06-30 | Petitioner | Semenza, HIF-1 and human disease | |
| 1010 | 2016-06-30 | Petitioner | U.S. Provisional Patent Application No. 60/337,082 | |
| 1011 | 2016-06-30 | Petitioner | U.S. Provisional Patent Application No. 60/349,659 | |
| 1012 | 2016-06-30 | Petitioner | U.S. Provisional Patent Application No. 60/359,683 | |
| 1013 | 2016-06-30 | Petitioner | U.S. Provisional Patent Application No. 60/386,488 | |
| 1014 | 2016-06-30 | Petitioner | U.S. Patent Appl. No. 10/313,551 | |
| 1015 | 2016-06-30 | Petitioner | Amendment After Allowability dated Mar. 15, 2013 | |
| 1016 | 2016-06-30 | Petitioner | Notice of Allowability dated Feb. 20, 2013 | |
| 1017 | 2016-06-30 | Petitioner | Freidman et al., Prolyl 4-hydroxylase | |
| 1018 | 2016-06-30 | Petitioner | Nwogu et al., Inhibition of collagen synthesis | |
| 1019 | 2016-06-30 | Petitioner | U.S. Patent No. 6,093,730 | |
| 1020 | 2016-06-30 | Petitioner | Franklin et al., Inhibition of prolyl ....... | |
| 1021 | 2016-06-30 | Petitioner | Kivirikko and Myllyharju, | |
| 1022 | 2016-06-30 | Petitioner | Chandel et al., Mitochondrial reactive oxygen | |
| 1023 | 2016-06-30 | Petitioner | Goldberg et al., Regulation of the Erythropoietin Gene | |
| 1024 | 2016-06-30 | Petitioner | Huang et al., Williams Hematology.. | |
| 1025 | 2016-06-30 | Petitioner | Ivan et al. HIFa Targeted for VHL-Mediated | |
| 1026 | 2016-06-30 | Petitioner | Lee et al., Hypoxia-inducible Factor-1 | |
| 1027 | 2016-06-30 | Petitioner | Bickel et al., Selective Inhibition of Hepatic Collagen | |
| 1028 | 2016-06-30 | Petitioner | Marti et al., Erythropoietin Gene Expression in Human | |
| 1029 | 2016-06-30 | Petitioner | Maxwell et al., The tumour suppressor protein | |
| 1030 | 2016-06-30 | Petitioner | Listing of the documents reviewed and relied upon by Paul Schumacker | |
| 1031 | 2016-06-30 | Petitioner | Roberto Bolli, The late phase of preconditioning | |
| 1032 | 2016-06-30 | Petitioner | Melillo et al., Regulation of Inducible Nitric | |
| 1033 | 2016-06-30 | Petitioner | Semenza, Hypoxia-inducible factor 1 | |
| 1034 | 2016-06-30 | Petitioner | Pugh et al., Activation of Hypoxia-inducible Factor-1 | |
| 1035 | 2016-06-30 | Petitioner | Jiang et al., Dimerization, DNA binding | |
| 1036 | 2016-06-30 | Petitioner | Kilic et al., Brain-derived erythropoietin | |
| 1037 | 2016-06-30 | Petitioner | Lee et al., Early expression of angiogenesis | |
| 1038 | 2016-06-30 | Petitioner | Myllyharju and Kivirikko | |
| 1039 | 2016-06-30 | Petitioner | Bergeron et al., Role of Hypoxia-Inducible | |
| 1040 | 2016-06-30 | Petitioner | Stoyanovsky and Cederbaum, Thiol | |
| 1041 | 2016-06-30 | Petitioner | Wasser et al., Liver Fibrosis | |
| 1042 | 2016-06-30 | Petitioner | Ambrosio et al., Reduction in experimental | |
| 1043 | 2016-06-30 | Petitioner | Reimer and Jennings, Myocardial Ischemia | |
| 1044 | 2016-06-30 | Petitioner | Choi and Alam, Heme Oxygenase-1.. Function | |
| 1045 | 2016-06-30 | Petitioner | Franklin et al., Approaches to the design of anti-fibrotic drugs | |
| 1047 | 2016-06-30 | Petitioner | Curriculum Vitae of Paul Schumacker, Ph.D. | |
| 3 | 2016-07-12 | Board | Notice of Filing Date | Notice of Accord Filing Date |
| 1046 | 2016-07-13 | Petitioner | Missing -Ex 1046 Leff and Schumacker 1993 | |
| 4 | 2016-07-14 | Petitioner | Other | Certificate of Service re Missing Exh. 1046-IPR2016-01315 |
| 5 | 2016-07-15 | Board | Notice of Filing Date | Notice of Accepting Corrected Petition |
| 6 | 2016-07-19 | Petitioner | Other | Motion for Lisa M. Ferri to Appear Pro Hac Vice |
| 1048 | 2016-07-19 | Petitioner | Ex. 1048- Declaration of Lisa M. Ferri in Support of Motion to Appear PHV | |
| 1049 | 2016-07-19 | Petitioner | Ex. 1049- Professional Profile of Lisa M. Ferri | |
| 7 | 2016-07-20 | Potential Patent Owner | Mandatory Notice | Patent Owner Mandatory Notice Information |
| 8 | 2016-07-20 | Potential Patent Owner | Power of Attorney | Patent Owner Power of Attorney |
| 9 | 2016-10-12 | Potential Patent Owner | Preliminary Response | Patent Owner Preliminary Response |
| 10 | 2016-10-12 | Potential Patent Owner | Patent Owner Exhibit List | |
| 2001 | 2016-10-12 | Potential Patent Owner | Exhibit 2001 | |
| 2002 | 2016-10-12 | Potential Patent Owner | Exhibit 2002 | |
| 2003 | 2016-10-12 | Potential Patent Owner | Exhibit 2003 | |
| 2004 | 2016-10-12 | Potential Patent Owner | Exhibit 2004 | |
| 2005 | 2016-10-12 | Potential Patent Owner | Exhibit 2005 | |
| 2006 | 2016-10-12 | Potential Patent Owner | Exhibit 2006 | |
| 2007 | 2016-10-12 | Potential Patent Owner | Exhibit 2007 | |
| 2008 | 2016-10-12 | Potential Patent Owner | Exhibit 2008 | |
| 2010 | 2016-10-12 | Potential Patent Owner | Exhibit 2010 | |
| 2011 | 2016-10-12 | Potential Patent Owner | Exhibit 2011 | |
| 11 | 2017-01-11 | Board | Institution Decision | Trial Instituted Document |
| 12 | 2017-02-24 | Petitioner | Other | Request for Refund - patent 172 |
| 13 | 2017-03-09 | Board | Other | Notice of Refund |
Grounds Asserted